Pharmaceutical Executive-06-01-2013

Despite their high status, management gurus aren't always on point when it comes to pharma, writes John Ansell.

Getting patients to take their medicine on spec and on time is the challenge that never goes away-it's the deadweight baggage accompanying every industry innovation since the arrival of aspirin a century ago.

What is really driving decision making by the new Brazilian HTA agency? A look at appraisals issued in the first year.

Ireland has been a pharma industry darling since the 1960s, when a then-newly established IDA targeted the sector as a strategic area for development. Today, the numbers are eyecatching. As reported by the IDA, nine out of the top 10 pharma companies in the world have substantial manufacturing operations in Ireland.

Customer-focused supply-chain capabilities are becoming a more important part of a company's competitive advantage.

S

Compounders are under increased scrutiny following last year's spinal meningitis outbreak.

Led by two New Yorkers with a mindset that marries novel scientific insights to the processing power of novel technologies, Regeneron's success is a revolutionary challenge to the industry status quo.

Project Data Sphere aims to liberate clinical trial data sets from industry and academic vaults, in an attempt to catalyze cancer research and discovery.